Japanese nation-wide prospective observational study on the current state and efficacy of therapeutics for large vessel vasculitis, -Takayasu's arteritis and Giant cell arteritis-

Japanese nation-wide prospective observational study on the current state and efficacy of therapeutics for large vessel vasculitis, -Takayasu's arteritis and Giant cell arteritis- - Japanese nation-wide prospective observational study on the current state and efficacy of therapeutics for large vessel vasculitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010414

Enrollment

Registered

2013-04-03

Start date

2012-11-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Large Vessel Vasculitis (Takayasu&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Newly diagnosed patients with large vessel vasculitis including Takayasu's arteritis and Giant cell arteritis

Exclusion criteria

Exclusion criteria: 1) the patients with Buerger's disease 2) the patients with malignant disease 3) the patients who their primary doctors consider as inappropriate 4) the patients who disagree to participate in this study

Design outcomes

Primary

Measure	Time frame
the remission rate of Takayasu's arteritis and Giant cell arteritis	—

Secondary

Measure	Time frame
1) survival rate 2) cause of death 3) responder rate of the therapy 4) relapse rate 5) incidence rate of the infectious disease and the analysis of its risk factor 6) concordance rate of current diagnostic criteria and classification of large vessel vasculitis 7) pathological condition of Takayasu's arteritis and Giant cell arteritis 8) identification of the candidate of new biomaker of large vessel vasculitis 9) identification of the new diagnostic imaging method	—

Measure

Time frame

1) survival rate 2) cause of death 3) responder rate of the therapy 4) relapse rate 5) incidence rate of the infectious disease and the analysis of its risk factor 6) concordance rate of current diagnostic criteria and classification of large vessel vasculitis 7) pathological condition of Takayasu's arteritis and Giant cell arteritis 8) identification of the candidate of new biomaker of large vessel vasculitis 9) identification of the new diagnostic imaging method

—

Countries

Japan

Contacts

Public ContactHaruhito Uchida

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Medicine and Clinical Sciences

hauchida@md.okayama-u.ac.jp086-235-7235

Outcome results